STEMLINE THERAPEUTICS INC - COM (STML)

CUSIP: 85858C107

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
12,610,577
Share change
-1,224,642
Total reported value
$116,017,342
Put/Call ratio
24%
Price per share
$9.20
Number of holders
69
Value change
-$9,853,957
Number of buys
32
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 85858C107?
CUSIP 85858C107 identifies STML - STEMLINE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of STEMLINE THERAPEUTICS INC - COM (STML) as of Q2 2017

As of 30 Jun 2017, STEMLINE THERAPEUTICS INC - COM (STML) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,610,577 shares. The largest 10 holders included FMR LLC, BlackRock Inc., FARALLON CAPITAL MANAGEMENT LLC, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, AXA, INTERNATIONAL BIOTECHNOLOGY TRUST PLC, STATE STREET CORP, and MILLENNIUM MANAGEMENT LLC. This page lists 69 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.